Edition:
United Kingdom

People: GN Store Nord A/S (GN.CO)

GN.CO on Copenhagen Stock Exchange

328.30DKK
3:59pm BST
Change (% chg)

kr.2.10 (+0.64%)
Prev Close
kr.326.20
Open
kr.326.20
Day's High
kr.331.30
Day's Low
kr.325.60
Volume
401,051
Avg. Vol
389,068
52-wk High
kr.346.60
52-wk Low
kr.226.70

Wold-Olsen, Per 

Mr. Per Wold-Olsen has served as Independent Chairman of the Board of Directors of GN Store Nord A/S since June 2008. He also chairs the Company’s Remuneration and Nomination Committees and holds a Member position on the Strategy Committee. Mr. Wold-Olsen has over 30 years of executive experience from Merck & Co., Inc. He joined the company in 1991 and held various assignments. From 1994 to 2006 he was Member of the company’s Management Committee. In 2006, he retired from Merck as President of the Intercontinental Division (Europe, Eastern Europe, Africa, the Middle East, India, Latin America and Africa). He started his career as Managing Director in pharmaceutical company MSD Norway (1976-1991). Mr. Wold-Olsen serves as Chairman of the Boards of GN Audio A/S and GN Hearing A/S, Chairman of the Board of Medicines for Malaria Venture and Oncopeptides AB ans member of the board of Gilead Sciences Inc. He has global leadership experience and knowledge of the healthcare industry. He has capabilities within marketing and product development, as well as commercialization of innovation. He has knowledge of United States market and emerging markets. He obtained Master of Business Administration degree.

Basic Compensation

Total Annual Compensation, DKK 2,035,000
Restricted Stock Award, DKK --
Long-Term Incentive Plans, DKK --
All Other, DKK --
Fiscal Year Total, DKK 2,035,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Per Wold-Olsen

2,035,000

William Hoover

1,348,000

Marcus Desimoni

11,600,000

Jakob Gudbrand

--

Rene Svendsen-Tune

15,000,000

Morten Andersen

275,000
As Of  31 Dec 2018